Malaysia vs North Macedonia: Share of people with HIV who receive antiretroviral therapy
Malaysia
60.0%
in 2024
North Macedonia
59.0%
in 2024
Malaysia rank
106th
North Macedonia rank
109th
Share of people with HIV who receive antiretroviral therapy over time
- Malaysia
- North Macedonia
How they compare
Malaysia currently reports 60.0% against 59.0% in North Macedonia, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was North Macedonia ahead.
Malaysia ranks 106th and North Macedonia ranks 109th of 143 countries.
Across the 3 decades both report, Malaysia averaged higher in 1 and North Macedonia in 2.
Head to head by decade
| Decade | Malaysia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.8% | 11.1% | 2.3% | North Macedonia |
| 2010s | 33.9% | 34.8% | 0.9% | North Macedonia |
| 2020s | 57.6% | 54.6% | 3.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Malaysia or North Macedonia?
- Malaysia, at 60.0% against 59.0% in North Macedonia as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Malaysia and North Macedonia?
- 1.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and North Macedonia rank globally for share of people with hiv who receive antiretroviral therapy?
- Malaysia ranks 106th and North Macedonia ranks 109th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.